Cdk5 phosphorylation-dependent C9orf72 degradation promotes neuronal death in Parkinson's disease models

Xingfeng Xu1,2, Mao Li1,2, Yan Su1,2

  • 1Department of Physiology, Guilin Medical University, Guilin, Guangxi, China.

PubMed
Abstract

Insights

Chromosome 9 open reading frame 72 (C9orf72) protein levels decrease in Parkinson's disease (PD) due to Cdk5 phosphorylation and degradation. Restoring C9orf72 function alleviates neuronal death and motor deficits in PD models.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • The role of Chromosome 9 open reading frame 72 (C9orf72) in Parkinson's disease (PD) pathogenesis is currently unknown.
  • C9orf72 is implicated in various neurodegenerative diseases, highlighting its potential significance in neurological disorders.

Purpose of the Study:

  • To investigate the potential mechanism of C9orf72 in the pathogenesis of Parkinson's disease.
  • To explore the relationship between C9orf72, Cdk5, and neuronal death in PD.

Main Methods:

  • Examined C9orf72 expression and phosphorylation using Western blotting, RT-PCR, and immunoprecipitation in PD models.
  • Utilized bioinformatics to predict Cdk5 phosphorylation sites on C9orf72 and tested Cdk5 inhibitor ROSCOVITINE.
  • Constructed C9orf72 knockdown and overexpression models, and employed a peptide to interfere with Cdk5 phosphorylation.

Main Results:

  • C9orf72 protein levels were reduced, while mRNA remained unchanged in PD models, with increased phosphorylation.
  • Cdk5 directly phosphorylated C9orf72 at Ser9, promoting its degradation via the ubiquitin-proteasome pathway.
  • C9orf72 knockdown exacerbated PD symptoms, while overexpression and Cdk5 phosphorylation interference alleviated neuronal dysfunction and motor deficits.

Conclusions:

  • C9orf72 plays a crucial role in regulating neuronal death during Parkinson's disease progression.
  • Cdk5-dependent degradation of C9orf72 is a key mechanism contributing to PD pathogenesis.
  • Targeting Cdk5 phosphorylation of C9orf72 may offer a therapeutic strategy for Parkinson's disease.